Greenbrook TMS, Inc. (GBNH)

NASDAQ: GBNH · IEX Real-Time Price · USD
3.34
+0.14 (4.38%)
At close: Oct 5, 2022 4:00 PM
3.18
-0.16 (-4.79%)
Pre-market: Oct 5, 2022 5:52 PM EDT

Company Description

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States.

Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services.

As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts.

Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Greenbrook TMS, Inc.
Greenbrook TMS logo
Country Canada
Founded 2011
Industry Medical Care Facilities
Sector Health Care
Employees 394

Contact Details

Address:
890 Yonge Street
Toronto, ON M4W 3P4
Canada
Phone 416 621 4642
Website greenbrooktms.com

Stock Details

Ticker Symbol GBNH
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 1735948
ISIN Number CA3937043097

Key Executives

Name Position
William P. Leonard President, Chief Executive Officer and Director
Erns Loubser C.A., C.F.A. Chief Financial Officer and Treasurer
Diana Shi Senior Vice President of Operations
Euphia Hsu Smith Chief Marketing Officer
Benjamin Klein Chief Executive Officer
Glen Akselrod Investor Relations Officer
Iris Krug Vice President of Compliance and Privacy Officer
Brittany Schwemmer Vice President of Human Resources
Dr. Geoffrey Grammer M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Aug 2, 2022 6-K Report of foreign issuer
Jul 28, 2022 D Notice of Exempt Offering of Securities
Jul 28, 2022 6-K Report of foreign issuer
Jul 27, 2022 SC 13D General statement of acquisition of beneficial ownership
Jul 25, 2022 SC 13G Statement of acquisition of beneficial ownership by individuals
Jul 22, 2022 6-K Report of foreign issuer
Jul 14, 2022 6-K Report of foreign issuer
Jun 27, 2022 6-K Report of foreign issuer
Jun 22, 2022 6-K Report of foreign issuer
Jun 1, 2022 6-K Report of foreign issuer